ArticleCancer science2026

In-Tumor CRISPR-Cas9 Knockout Screening and Novel Therapy Development for Malignant Transformation of Ovarian Teratoma.

Satoshi Tamauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.